pharmaceuticals
ViiV Healthcare
Website: viivhealthcare.com
Overview
ViiV Healthcare is a British multinational pharmaceutical company dedicated to the research, development, and commercialization of medicines for the treatment and prevention of HIV/AIDS. Founded in 2009 as a joint venture between GlaxoSmithKline and Pfizer, with Shionogi joining in 2012, ViiV Healthcare focuses exclusively on HIV care and innovation.
The company offers a portfolio of 17 prescription medicines that include antiretroviral therapies and pre-exposure prophylaxis (PrEP). ViiV Healthcare holds approximately 32% of the global HIV therapy market, making it the second-largest player in this sector. Its research and development efforts are centered at a dedicated HIV research facility in Branford, Connecticut, which is the only HIV-focused research center in the world.
ViiV Healthcare operates globally, with headquarters in London and additional sites in various countries. The company emphasizes a holistic approach, partnering with people living with HIV and their communities to inform its strategies and ensure equitable access to its medicines.
The company offers a portfolio of 17 prescription medicines that include antiretroviral therapies and pre-exposure prophylaxis (PrEP). ViiV Healthcare holds approximately 32% of the global HIV therapy market, making it the second-largest player in this sector. Its research and development efforts are centered at a dedicated HIV research facility in Branford, Connecticut, which is the only HIV-focused research center in the world.
ViiV Healthcare operates globally, with headquarters in London and additional sites in various countries. The company emphasizes a holistic approach, partnering with people living with HIV and their communities to inform its strategies and ensure equitable access to its medicines.
Est Monthly Spend
---
Repeat Buy Rate
---
Direct Response
---
Est. Spend
No spend data available
Top Shows
Ads
Recent Campaigns